X
Email:
sales@ruixibiotech.com

SB239063 CAS:193551-21-2

SB239063

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-C-1131 10mg 165.00
- +
+ Add to cart
R-C-1131 25mg 350.00
- +
+ Add to cart
R-C-1131 50mg 640.00
- +
+ Add to cart

Product description

SB 239063 is a selective p38 MAPK inhibitor(IC50=44 nM for recombinant purified p38α).1 It displays greater than 220-fold selectivity for p38 MAPK over ERK, JNK1,and other kinases.1 SB 239063 has been shown to reduce inflammatory cytokine production in lipopolysaccharide-stimulated human peripheral blood monocytes(IC50s=0.12 and 0.35 µM,respectively for IL-1 and TNF-α)and is neuroprotective following oral administration in a rat model of cerebral focal ischemia.


Appearance N/A
Molecular Weight N/A
purity >95%
PDI by GPC <1.5
Solubility N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 2 weeks
Stability 1 year
Document

Related Product